文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

水痘疫苗接种可降低不同队列水痘相关住院风险(意大利,2003-2018)

Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Italy, 2003-2018).
PubMed 文献 · Vaccine · 2020-07-10

该研究基于意大利2003-2018年医院出院记录和24月龄水痘疫苗覆盖率数据,回顾性分析水痘相关住院率变化。结果显示疫苗接种引入后住院率显著下降(3.4 vs 2.7/10万,p<0.001),<1岁和1-5岁儿童住院率年均变化分别为-35.0%和-35.2%。结论认为住院率与疫苗覆盖率和接种引入年数密切相关,普遍接种是降低并发症风险的重要公共卫生策略。

要点

  • 水痘疫苗接种引入后,水痘相关住院率显著下降(3.4 vs 2.7/10万,p<0.001)。
  • 接种后前5年,<1岁婴儿和1-5岁儿童住院率年均下降约35%。
  • 住院率下降与疫苗覆盖率和接种引入年数密切相关。

核心结论

  • 水痘疫苗接种可降低已接种和未接种队列的水痘相关住院风险。
  • 住院率与疫苗接种覆盖率和接种引入年数严格相关。
  • 普遍接种并保持高覆盖率是减少水痘并发症风险的有力工具。

研究设计与样本

  • 回顾性观察性研究,基于意大利卫生部2003-2018年医院出院记录和24月龄水痘疫苗覆盖率数据。
  • 以ICD-9 CM 052.X作为主要诊断或五个次要诊断中任一项的住院记录定义为水痘相关住院。
  • 通过连接点分析计算平均年度百分比变化(AAPC)评估住院率变化。

主要发现

  • 住院率随年龄呈下降趋势:<1岁儿童为42.5/10万/年,1-5岁为23.8/10万,后续年龄组<4.0/10万。
  • 疫苗接种引入后水痘住院率显著下降(3.4 vs 2.7/10万;p<0.001)。
  • 接种后前5年,<1岁婴儿住院率AAPC为-35.0%(p<0.001),1-5岁儿童AAPC为-35.2%(p<0.01)。
  • <1岁和1-5岁年龄组总百分比变化分别为-80.0%和-86.7%。

临床怎么用

  • 应重视水痘疫苗普遍接种策略,并努力提高疫苗接种覆盖率以降低水痘相关住院风险。
  • 监测水痘相关住院率变化可评估疫苗接种规划的公共卫生影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The present study summarizes evidences of the impact that varicella vaccination (VV) introduction and coverage can have on varicella attributable hospitalization rates. METHODS: A retrospective observational study was carried out by considering hospital discharge records and VV coverage at 24 months collected from 2003 to 2018 by the Italian Ministry of Health. All hospitalizations records reporting an ICD-9 CM 052.X code as the principal diagnosis or any of the five secondary diagnoses were considered as related to varicella. The hospitalization rate reduction was evaluated by calculating average annual percent change (AAPC) through joint-point analysis. RESULTS: Hospitalization rates showed a decreasing trend by age: children <1 year of age were the most affected group in each Italian administrative region (42.5/100,000 per year), whereas lower incidence rates were found in older age groups (23.8/100,000 in 1-5 years old and <4.0/100,000 in the following groups). Varicella hospitalization rates decreased significantly after the introduction of VV (3.4 vs. 2.7 per 100,000; p < 0.001). During the first five years after the introduction of vaccination, hospitalization rates showed a statistically significant decrease especially among infants <1 year of age (AAPC -35.0%; p < 0.001) and 1-5 years old (AAPC -35.2%; p < 0.01). Total percentage changes were -80.0% and -86.7%, in the age class <1 year old and 1-5 years old, respectively. CONCLUSIONS: All the previously reported findings confirm that hospitalization rates are strictly related to both the vaccination coverage and the number of years since the introduction of the vaccination. VV confirms to be an important step in public health strategies and the introduction of universal vaccination, with high vaccination coverage, should be considered as an extremely powerful tool to reduce the risk of complications.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Amodio E, Casuccio A, Tramuto F, et al. Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Italy, 2003-2018). Vaccine. 2020. PMID: 32654900. doi:10.1016/j.vaccine.2020.06.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。